Skip to content
Search

Latest Stories

Wales to launch first Women's Health Research Centre in April

£3 million funding boost for women's health research in Wales
A £3 million investment has been allocated for first Women's Health Research Centre in Wales (gettyimages)

As part of Women’s Health Plan for Wales, £750,000 will be spent on research for women’s health conditions

A dedicated Women’s Health Research Centre is set to open in Wales this April, as part of the Welsh government’s plan to close the gender health gap.

The centre, a first-of-its-kind in Wales, has received a £3 million investment from Health and Care Research Wales. This is on top of £750,000 available for other dedicated women’s health research projects.


The first Women’s Health Plan for Wales, published in December 2023, outlined a commitment to launching a call for women’s health research with a budget of £750,000 in April 2025 and encouraged Welsh universities to bid for catalytic funding to create a Women’s Health Research Centre.

Now, funding of £3,013,936 has been secured, as part of a wider £49 million funding package announced by Health and Care Research Wales to support 17 research centres across the country.

Sarah Murphy, minister for mental health and wellbeing, with responsibility for women’s health, emphasised the importance of creating the new research centre, stating that it will helping them to “better understand women's experiences, develop more effective treatments, and ensure our health services truly meet women's needs at every stage of their lives.”

“I hope the centre will attract and retain leading researchers in the field and help ensure Welsh women's experiences and needs drive our women’s health plan for Wales,” she said.

The Women’s Health Network, part of the NHS Wales Executive, will collaborate with Health and Care Research Wales and the academic community to develop the data and evidence that is specific to women.

Dr Helen Munro, national clinical lead for women’s health, welcomed the investment, stating: “This is an encouraging step towards achieving a more equal healthcare system for women in Wales and represents a real investment in our future health.”

Research indicates that while women live longer than men, they spend more years living with disabilities, wait longer for pain relief, and often have their symptoms dismissed.

The Women’s Health Plan for Wales set out a 10-year vision to improve healthcare services for women.

Developedby the National Strategic Clinical Network for Women’s Health, the plan details how NHS organisations in Wales will close the gender health gap by providing better health services for women, ensuring they are listened to, and their health needs are understood.

Comprising nearly 60 actions across eight priority areas, the plan aims to enhance women's healthcare throughout their lifetime.

As part of this initiative, women's health hubs will also be established across Wales by 2026.

Additionally, the plan includes a commitment to ‘Make Every Contact Count,’ encouraging healthcare professionals to discuss menstrual health and menopause with women during routine appointments.

The plan, which will be added to over time, covers:

  • Menstrual Health
  • Endometriosis and Adenomyosis
  • Contraception, Post-Natal Contraception and Abortion Care
  • Preconception Health
  • Pelvic Health and Incontinence
  • Menopause
  • Violence against Women and Girls
  • Ageing Well and Long-Term Conditions Across the Life Course.

The NHS Executive will oversee the governance and implementation of the plan, with annual reports submitted to the Welsh Government on behalf of NHS Wales.

More For You

Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Trump signs executive order to accelerate US-based pharmaceutical manufacturing plants

US president Donald Trump

Pic credit: Getty Images

Trump signs executive order to encourage US drug manufacturing

US president Donald Trump signed an executive order on Monday that aims to reduce the time it takes to approve pharmaceutical plants in the country, as part of new regulations to encourage domestic manufacturing.

The order directs the US Food and Drug Administration to streamline reviews and work with domestic manufacturers to provide early support before facilities come online.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less
NICE approves once-daily tablet Linzagolix for endometriosis

NICE recommends Linzagolix with add-back therapy for endometriosis

Image credit: Getty Images

NICE approves new at-home treatment for endometriosis

The National Institute for Health and Care Excellence (NICE) has recommended Linzagolix (brand name Yselty), a once-daily tablet, as a new treatment option for endometriosis.

Developed by Theramex, Linzagolix is approved for use alongside hormonal add-back therapy in adults of reproductive age who have previously tried other medical or surgical treatments for the condition.

Keep ReadingShow less